Dynatronics Corporation (DYNT) Research

Dynatronics Corporation functions as a medical device firm dedicated to the creation, production, and distribution of essential products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. While its primary market is the United States, the company also exports its goods to approximately 30 international locations. The company's diverse product range includes an extensive selection of orthopedic soft bracing solutions, such as cervical collars, shoulder immobilizers, arm slings, supports for wrists, elbows, abdominals, and lumbosacral regions, as well as maternity supports, knee immobilizers, ankle walkers, plantar fasciitis splints, and cold therapy items. Additionally, Dynatronics provides advanced therapeutic modality devices. These encompass systems for electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold treatment, compression therapy, and various electrodes. For clinical environments, their offerings extend to a variety of powered and manually operated treatment tables, mat platforms, specialized work tables, parallel bars, training stairs, weight racks, treadmills, and other associated exercise equipment. Complementing these, the company supplies crucial clinical consumables like exercise bands and tubing, lotions and gels, additional orthopedic bracings, paper products, and sundry related supplies. These varied products are sold under established brands such as Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM. Dynatronics serves a broad professional clientele, including orthopedists, physical therapists, chiropractors, athletic trainers, and sports medicine practitioners, in addition to clinics and hospitals, leveraging both direct sales and an online platform. Founded in 1979, the corporation is headquartered in Eagan, Minnesota.

Open Dynatronics Corporation (DYNT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.